{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:34:23Z","timestamp":1791592463350,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23hk0102095"],"award-info":[{"award-number":["JP23hk0102095"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12928-026-01280-4","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:04:20Z","timestamp":1775664260000},"page":"628-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paclitaxel drug-coated balloon angioplasty for de novo coronary lesions in an expanded real world clinical setting: the multicenter ALLIANCE registry"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-3469","authenticated-orcid":false,"given":"Masato","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehiro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisuke","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Nozoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Morishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ALLAINCE registry investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","volume":"76","author":"S Kufner","year":"2020","unstructured":"Kufner S, Ernst M, Cassese S, Joner M, Mayer K, Colleran R, et al. 10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents. J Am Coll Cardiol. 2020;76:146\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"1280_CR2","doi-asserted-by":"crossref","unstructured":"Saito S, Bennett J, Nef HM. Webster M, Namiki A, Takahashi T, Kakuta T, et al. Percutaneous coronary treatment with bioadaptor implant vs drug-eluting stent: 2-year outcomes from BIOADAPTOR RCT. JACC Cardiovasc Interv. 2025;18: 988\u2013997.","DOI":"10.1016\/j.jcin.2025.01.426"},{"key":"1280_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2024.08.067","volume":"85","author":"X Gao","year":"2025","unstructured":"Gao X, Tian N, Kan J, Li P, Wang M, Sheiban I, et al. Drug-coated balloon angioplasty of the side branch during provisional stenting: the multicenter Randomized DCB-BIF Trial. J Am Coll Cardiol. 2025;85:1\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"1280_CR4","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA, Mangner N, M\u00f6bius-Winkler S, Weilenmann D, et al. Long-term efficacy and safety of drug-coated balloons versus drugeluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396:1504\u201310.","journal-title":"Lancet"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","volume":"12","author":"NS Vos","year":"2019","unstructured":"Vos NS, Fagel ND, Amoroso G, Herrman JR, Patterson MS, Piers LH, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv. 2019;12:1691\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"1280_CR6","doi-asserted-by":"publisher","first-page":"e1322","DOI":"10.4244\/EIJ-D-23-00868","volume":"20","author":"B Scheller","year":"2024","unstructured":"Scheller B, Mangner N, Jeger RV, Afan S, Mahfoud F, Woitek FJ, et al. A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions. EuroIntervention. 2024;20:e1322\u20139.","journal-title":"EuroIntervention"},{"key":"1280_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jcin.2024.04.014","volume":"17","author":"XF Gao","year":"2024","unstructured":"Gao XF, Ge Z, Kong XQ, Chen X, Han L, Qian XS, et al. Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: The ULTIMATE III Trial. JACC Cardiovasc Interv. 2024;17:1519\u201328.","journal-title":"JACC Cardiovasc Interv"},{"key":"1280_CR8","doi-asserted-by":"crossref","unstructured":"Muramatsu T, Kozuma K, Tanabe K, Morino Y, Ako J, Nakamura S, et al. Task Force of the Japanese Association of Cardiovascular Intervention, Therapeutics (CVIT). Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2023;38:166\u2013176","DOI":"10.1007\/s12928-023-00921-2"},{"key":"1280_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jacc.2025.07.049","volume":"86","author":"S Fezzi","year":"2025","unstructured":"Fezzi S, Serruys PW, Cortese B, Scheller B, Alfonso F, Jeger R, et al. Indications for use of drug-coated balloons in coronary intervention: academic research consortium position statement. J Am Coll Cardiol. 2025;86:1170\u2013202.","journal-title":"J Am Coll Cardiol"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/eurheartj\/ehaf029","volume":"46","author":"S Fezzi","year":"2025","unstructured":"Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, et al. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. Eur Heart J. 2025;46:2498\u2013519.","journal-title":"Eur Heart J"},{"key":"1280_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9149(91)90780-O","volume":"68","author":"MS Huber","year":"1991","unstructured":"Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68:467\u201371.","journal-title":"Am J Cardiol"},{"key":"1280_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"1280_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Circulation. 2019;140:240\u201361.","journal-title":"Circulation"},{"key":"1280_CR14","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","volume":"60","author":"J W\u00f6hrle","year":"2012","unstructured":"W\u00f6hrle J, Zadura M, M\u00f6bius-Winkler S, Leschke M, Opitz C, Ahmed W, et al. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. JACC. 2012;60:1733\u20138.","journal-title":"JACC"},{"key":"1280_CR15","doi-asserted-by":"crossref","unstructured":"Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, et al. Sirolimus-coated balloon in an all-comer population of coronary artery disease patients. The EASTBOURNE Prospective Registry. J Am Coll Cardiol Intv. 2023;16:1794\u2013180","DOI":"10.1016\/j.jcin.2023.05.005"},{"key":"1280_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12928-023-00953-8","volume":"39","author":"M Nakamura","year":"2024","unstructured":"Nakamura M, Isawa T, Nakamura S, Ando K, Namiki A, Shibata Y, et al. One-year safety and effectiveness of the Agent paclitaxel-coated balloon for the treatment of small vessel disease and in-stent restenosis. Cardiovasc Interv Ther. 2024;39:47\u201356.","journal-title":"Cardiovasc Interv Ther"},{"key":"1280_CR17","doi-asserted-by":"publisher","first-page":"e818","DOI":"10.4244\/EIJ-D-23-01006","volume":"20","author":"T Lee","year":"2024","unstructured":"Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, Miyazaki R, et al. Predictors of target lesion failure after percutaneous coronary intervention with a drug coated balloon for de novo lesions. EuroIntervention. 2024;20:e818\u201325.","journal-title":"EuroIntervention"},{"key":"1280_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4244\/EIJ-D-23-00849","volume":"20","author":"M Yamamoto","year":"2024","unstructured":"Yamamoto M, Hara H, Kubota S, Hiroi Y. Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions. EuroIntervention. 2024;20:602\u201312.","journal-title":"EuroIntervention"},{"key":"1280_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","volume":"404","author":"C Gao","year":"2024","unstructured":"Gao C, He X, Ouyang F, Zhang Z, Shen G, Wu M, et al. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial. Lancet. 2024;404:1040\u20135.","journal-title":"Lancet"},{"key":"1280_CR20","first-page":"544","volume":"100","author":"A Greco","year":"2022","unstructured":"Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, et al. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial. Catheter Cardiovasc Interv. 2022;100:544\u201352.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1280_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ahj.2023.01.007","volume":"258","author":"C Spaulding","year":"2023","unstructured":"Spaulding C, Krackhardt F, Bogaerts K, Urban P, Meis S, Morice MC, et al. Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: design and rationale of the SELUTION DeNovo Trial. Am Heart J. 2023;258:77\u201384.","journal-title":"Am Heart J"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01280-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:04:42Z","timestamp":1781809482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-026-01280-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01280-4","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. M Nakamura has received honoraria from Boston Scientific Japan Co., Ltd. and Nipro Corporation and research funding from Nipro Corporation, and is affiliated with an endowed course provided by Boston Scientific Japan Co., Ltd. and Nipro Corporation. Dr. Tanabe has received honoraria from Boston Scientific Japan K.K. and Abbott Japan LLC. Dr. Ando has received lecture fees from Abbott Japan LLC. Dr. Muramatsu has received honoraria from Boston Scientific Japan K.K. Dr. Dr. Kinoshita has received honoraria from Boston Scientific Japan K.K and TERUMO CORPORATION. Dr. Kozuma has received honoraria from Abbott Medical and Boston Scientific and research funding from Abbott Medical, and has served on advisory committees for both companies. Drs. Kadota, Tadano, S Nakamura, Ashikaga, Kuriyama, Kataoka, Nishida, Iijima, Nozoe, Morishige, Murakami, and Takahashi have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}